Search Results 1431-1440 of 5233 for Incineration

  1. Surgical Oncology and Endocrine Surgery in Arizona - Conditions treated - Mayo Clinic

    Mayo Clinic in Arizona offers subspecialty expertise in surgical cancer treatment within the Division of Surgical Oncology and Endocrine Surgery.

  2. Clinical trials - Oncology (Medical)

    Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

  3. Clinical trials - Oncology (Medical)

    Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by ...

  4. Clinical trials - Oncology (Medical)

    Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

  5. Efficacy in iNPH Shunting (PENS) Trial - Mayo Clinic

    The Placebo-Controlled Efficacy in Idiopathic Normal Pressure Hydrocephalus (iNPH) Shunting (PENS) trial is an investigation of cerebrospinal fluid (CSF) shunt ...

  6. Ablation therapy - Doctors & Departments - Mayo Clinic

    Ablation therapy is a procedure used to destroy abnormal tissue. Learn about the many different conditions treated with this minimally invasive treatment.

  7. Clinical trials - Oncology (Medical)

    Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

  8. Clinical trials - Oncology (Medical)

    Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by ...

  9. Ablation therapy - Doctors & Departments - Mayo Clinic

    Ablation therapy is a procedure used to destroy abnormal tissue. Learn about the many different conditions treated with this minimally invasive treatment.

  10. Clinical trials - Oncology (Medical)

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor ...